Stevens Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,227
| Closed | -$214K | – | 277 |
|
|
2025
Q4 | $214K | Buy |
+2,227
| New | +$216K | 0.08% | 194 |
|
|
2024
Q4 | – | Sell |
-10,536
| Closed | -$949K | – | 349 |
|
|
2024
Q3 | $949K | Buy |
+10,536
| New | +$886K | 0.14% | 79 |
|
|
2024
Q1 | – | Sell |
-5,183
| Closed | -$427K | – | 323 |
|
|
2023
Q4 | $427K | Buy |
+5,183
| New | +$395K | 0.11% | 167 |
|
|
2023
Q1 | – | Sell |
-3,818
| Closed | -$297K | – | 218 |
|
|
2022
Q4 | $297K | Buy |
+3,818
| New | +$309K | 0.19% | 90 |
|
|
2022
Q1 | – | Sell |
-43,620
| Closed | -$4.51M | – | 282 |
|
|
2021
Q4 | $4.51M | Buy |
+43,620
| New | +$5.05M | 1.04% | 22 |
|
|
2021
Q3 | – | Sell |
-4,714
| Closed | -$585K | – | 230 |
|
|
2021
Q2 | $585K | Buy |
4,714
+983
| +26% | +$123K | 0.17% | 98 |
|
|
2021
Q1 | $441K | Buy |
+3,731
| New | +$437K | 0.24% | 63 |
|
|
2020
Q4 | – | Sell |
-88,440
| Closed | -$9.19M | – | 199 |
|
|
2020
Q3 | $9.19M | Buy |
+88,440
| New | +$8.88M | 3.41% | 6 |
|
|
2020
Q1 | – | Sell |
-61,675
| Closed | -$7M | – | 258 |
|
|
2019
Q4 | $7M | Buy |
61,675
+45,064
| +271% | +$4.94M | 0.65% | 34 |
|
|
2019
Q3 | $1.8M | Sell |
16,611
-198,340
| -92% | -$20.7M | 0.16% | 160 |
|
|
2019
Q2 | $20.9M | Sell |
214,951
-115,621
| -35% | -$10.6M | 0.94% | 24 |
|
|
2019
Q1 | $30.1M | Buy |
330,572
+271,435
| +459% | +$24.3M | 1.29% | 3 |
|
|
2018
Q4 | $5.38M | Sell |
59,137
-167,613
| -74% | -$15.7M | 0.28% | 109 |
|
|
2018
Q3 | $22.3M | Buy |
+226,750
| New | +$21M | 0.82% | 18 |
|
|
2018
Q1 | – | Sell |
-25,872
| Closed | -$2.09M | – | 882 |
|
|
2017
Q4 | $2.09M | Sell |
25,872
-47,706
| -65% | -$3.82M | 0.08% | 293 |
|
|
2017
Q3 | $5.72M | Buy |
73,578
+62,092
| +541% | +$5.16M | 0.21% | 142 |
|
|
2017
Q2 | $1.02M | Sell |
11,486
-28,188
| -71% | -$2.38M | 0.04% | 419 |
|
|
2017
Q1 | $3.2M | Sell |
39,674
-58,625
| -60% | -$4.58M | 0.12% | 234 |
|
|
2016
Q4 | $7M | Buy |
+98,299
| New | +$7.72M | 0.29% | 94 |
|
|
2016
Q2 | – | Sell |
-40,756
| Closed | -$3.06M | – | 1032 |
|
|
2016
Q1 | $3.06M | Buy |
40,756
+9,892
| +32% | +$745K | 0.12% | 223 |
|
|
2015
Q4 | $2.37M | Sell |
30,864
-72,476
| -70% | -$5.46M | 0.09% | 262 |
|
|
2015
Q3 | $6.92M | Sell |
103,340
-307,506
| -75% | -$22.6M | 0.32% | 91 |
|
|
2015
Q2 | $30.4M | Buy |
410,846
+403,467
| +5,468% | +$30.8M | 1.1% | 7 |
|
|
2015
Q1 | $575K | Sell |
7,379
-317,568
| -98% | -$24.1M | 0.02% | 540 |
|
|
2014
Q4 | $23.5M | Buy |
324,947
+246,062
| +312% | +$17.1M | 0.79% | 17 |
|
|
2014
Q3 | $4.89M | Buy |
78,885
+24,754
| +46% | +$1.57M | 0.15% | 182 |
|
|
2014
Q2 | $3.45M | Buy |
+54,131
| New | +$3.29M | 0.09% | 257 |
|
|
2014
Q1 | – | Sell |
-669,038
| Closed | -$38.4M | – | 1219 |
|
|
2013
Q4 | $38.4M | Buy |
+669,038
| New | +$37.9M | 1.13% | 11 |
|
Other funds holding MDT
VCM
VPM
Stevens Capital Management's MDT Position: Q1 2026 in Review
Stevens Capital Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,227 shares — an estimated $214K sold.
Stevens Capital Management first reported a position in MDT in Q4 2013 and held it in 28 quarters. The position peaked at $38.4M in Q4 2013. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Stevens Capital Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Stevens Capital Management sold 2,227 Medtronic shares in Q1 2026, an estimated $214K.
- Stevens Capital Management first reported a position in Medtronic in Q4 2013 and held it in 28 quarters.
- Stevens Capital Management's Medtronic position peaked at $38.4M in Q4 2013.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Stevens Capital Management's 13F filing for Q1 2026, filed 11 May 2026.